cafepharma updates · September 21 2026 - CagriSema tops Eli Lilly's tirzepatide for weight loss in late-stage diabetes trial — Pharmaceuticals newsletter ranking. Verify this listing to confirm the newsletter owner.
Confirm you publish cafepharma updates. We'll email you a one-click verification link. Verifying is free and unlocks:
Know who really runs cafepharma updates? Point us to them and we'll reach out to invite them to verify.